Erlotinib: early clinical development in brain cancer, Expert Opinion on Investigational Drugs, vol.63, issue.4, pp.1027-1037, 2014. ,
DOI : 10.1093/jnci/dji161
Prospective identification of tumorigenic breast cancer cells, Proceedings of the National Academy of Sciences, vol.17, issue.9, pp.3983-3988, 2003. ,
DOI : 10.1038/nm0901-1028
Mechanism of activation of protein kinase B by insulin and IGF-1, EMBO J, vol.15, issue.23, pp.6541-6551, 1996. ,
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response, Nature, vol.8, issue.7120, pp.756-760, 2006. ,
DOI : 10.1038/nn1473
Valproic Acid Use During Radiation Therapy for Glioblastoma Associated With Improved Survival, International Journal of Radiation Oncology*Biology*Physics, vol.86, issue.3, pp.504-509, 2013. ,
DOI : 10.1016/j.ijrobp.2013.02.012
URL : http://europepmc.org/articles/pmc4667941?pdf=render
Valproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results, Expert Opinion on Investigational Drugs, vol.52, issue.2, pp.1391-1415, 2012. ,
DOI : 10.1055/s-2008-1046473
Histone deacetylase inhibitors in glioblastoma: pre-clinical and clinical experience, Medical Oncology, vol.31, issue.suppl 4, p.985, 2014. ,
DOI : 10.1200/JCO.2013.49.6968
A Perivascular Niche for Brain Tumor Stem Cells, Cancer Cell, vol.11, issue.1, pp.69-82, 2007. ,
DOI : 10.1016/j.ccr.2006.11.020
LeX/ssea-1 Is Expressed by Adult Mouse CNS Stem Cells, Identifying Them as Nonependymal, Neuron, vol.35, issue.5, pp.865-875, 2002. ,
DOI : 10.1016/S0896-6273(02)00835-8
URL : https://doi.org/10.1016/s0896-6273(02)00835-8
Expression et localisation de la connexine 43 dans le glioblastome: implication pour la thérapie génique, 2008. ,
Loss of CIC and FUBP1 expressions are potential markers of shorter time to recurrence in oligodendroglial tumors, Modern Pathology, vol.15, issue.3, pp.332-342, 2014. ,
DOI : 10.1158/1078-0432.CCR-09-0867
A restricted cell population propagates glioblastoma growth after chemotherapy, Nature, vol.2, issue.7412, pp.522-526, 2012. ,
DOI : 10.1038/nature11287
URL : http://europepmc.org/articles/pmc3427400?pdf=render
Oncolytic viruses, Nature Reviews Cancer, vol.2, issue.12, pp.938-950, 2002. ,
DOI : 10.1038/nrc948
URL : https://hal.archives-ouvertes.fr/inserm-01644345
EGFR Antagonists in Cancer Treatment, New England Journal of Medicine, vol.358, issue.11, pp.1160-1174, 2008. ,
DOI : 10.1056/NEJMra0707704
Cancer Stem Cells???Perspectives on Current Status and Future Directions: AACR Workshop on Cancer Stem Cells, Cancer Research, vol.66, issue.19, pp.9339-9344, 2006. ,
DOI : 10.1158/0008-5472.CAN-06-3126
URL : http://cancerres.aacrjournals.org/content/66/19/9339.full.pdf
Prospective Identification of Tumorigenic Prostate Cancer Stem Cells, Cancer Research, vol.65, issue.23, pp.10946-10951, 2005. ,
DOI : 10.1158/0008-5472.CAN-05-2018
PLGA-based nanoparticles: An overview of biomedical applications, Journal of Controlled Release, vol.161, issue.2, pp.505-522, 2012. ,
DOI : 10.1016/j.jconrel.2012.01.043
Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: In vivo evaluation, International Journal of Pharmaceutics, vol.481, issue.1-2, pp.154-161, 2015. ,
DOI : 10.1016/j.ijpharm.2015.01.051
URL : https://hal.archives-ouvertes.fr/hal-01392431
[Cancer stem cells and future therapeutic implications], Rev Med Suisse, vol.7, issue.289, pp.774-777, 2011. ,
Defining the mode of tumour growth by clonal analysis, Nature, vol.96, issue.7412, pp.527-530, 2012. ,
DOI : 10.1038/nature11344
Identification and expansion of the tumorigenic lung cancer stem cell population, Cell Death & Differentiation, vol.161, issue.3, pp.504-514, 2008. ,
DOI : 10.1126/science.273.5272.242
Neurogenesis in the adult human hippocampus, Nature Medicine, vol.383, issue.11, pp.1313-1317, 1998. ,
DOI : 10.1038/383624a0
Cancer: une maladie des cellules souches ?, 2010. ,
Notch Pathway Blockade Depletes CD133-Positive Glioblastoma Cells and Inhibits Growth of Tumor Neurospheres and Xenografts, Stem Cells, vol.28, issue.1, pp.5-16, 2010. ,
DOI : 10.1002/stem.254
A Tumorigenic Subpopulation with Stem Cell Properties in Melanomas, Cancer Research, vol.65, issue.20, pp.9328-9337, 2005. ,
DOI : 10.1158/0008-5472.CAN-05-1343
Les Tumeurs Cérébrales Retrieved 28, 2015. ,
Telomerase inhibition improves tumor response to radiotherapy in a murine orthotopic model of human glioblastoma, Molecular Cancer, vol.42, issue.1, p.134, 2015. ,
DOI : 10.1158/0008-5472.CAN-06-2306
URL : https://hal.archives-ouvertes.fr/hal-01214043
Glioblastomes??: oncogen??se et bases biologiques, Neurochirurgie, vol.56, issue.6, pp.441-448, 2010. ,
DOI : 10.1016/j.neuchi.2010.07.010
ABCB5-Mediated Doxorubicin Transport and Chemoresistance in Human Malignant Melanoma, Cancer Research, vol.65, issue.10, pp.4320-4333, 2005. ,
DOI : 10.1158/0008-5472.CAN-04-3327
Phase III study of PSC-833 (valspodar) in combination with vincristine, doxorubicin, and dexamethasone (valspodar/VAD) versus VAD alone in patients with recurring or refractory multiple myeloma (E1A95), Cancer, vol.104, issue.1, pp.830-838, 2006. ,
DOI : 10.1002/cncr.21666
Temozolomide and treatment of malignant glioma, Clin Cancer Res, vol.6, issue.7, pp.2585-2597, 2000. ,
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma, Journal of Clinical Oncology, vol.27, issue.28, pp.4733-4740, 2009. ,
DOI : 10.1200/JCO.2008.19.8721
Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study, Journal of Clinical Oncology, vol.27, issue.12, pp.2052-2058, 2009. ,
DOI : 10.1200/JCO.2008.19.0694
Pathophysiological Roles of Mutations in the Electrogenic Na+-HCO3-Cotransporter NBCe1. Mutations in Human Genetic Disease, pp.167-180, 2012. ,
Surgical management for glioblastoma: technological evolutions, Académie nationale de chirurgie, vol.12, pp.67-072, 2013. ,
Gliomes c??r??braux, Cancer/Radioth??rapie, vol.14, issue.1, pp.14-22, 2010. ,
DOI : 10.1016/S1278-3218(10)70004-4
Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial, Neuro Oncol, vol.12, issue.5, pp.508-516, 2010. ,
CD90 is Identified as a Candidate Marker for Cancer Stem Cells in Primary High-Grade Gliomas Using Tissue Microarrays, Molecular & Cellular Proteomics, vol.28, issue.6, pp.111-010744, 2012. ,
DOI : 10.1038/nature09557
The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype, Cell Cycle, vol.8, issue.20, pp.3274-3284, 2009. ,
DOI : 10.4161/cc.8.20.9701
Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death, Proceedings of the National Academy of Sciences, vol.18, issue.46, pp.96-14276, 1999. ,
DOI : 10.1038/sj.onc.1203069
Convergence of IRBIT, phosphatidylinositol (4,5) bisphosphate, and WNK/SPAK kinases in regulation of the Na+-HCO3- cotransporters family, Proceedings of the National Academy of Sciences, vol.32, issue.suppl_2, pp.4105-4110, 2013. ,
DOI : 10.1093/nar/gkh468
Standards of care and novel approaches in the management of glioblastoma multiforme, Chinese Journal of Cancer, vol.33, issue.1, pp.32-39, 2014. ,
DOI : 10.5732/cjc.013.10207
Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma, Nature Reviews Cancer, vol.6, issue.5, pp.319-331, 2010. ,
DOI : 10.4161/cc.8.18.9504
Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro, Glia, vol.62, issue.3, pp.193-206, 2002. ,
DOI : 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C
SIN1/MIP1 Maintains rictor-mTOR Complex Integrity and Regulates Akt Phosphorylation and Substrate Specificity, Cell, vol.127, issue.1, pp.125-137, 2006. ,
DOI : 10.1016/j.cell.2006.08.033
URL : https://doi.org/10.1016/j.cell.2006.08.033
Radiotherapy for Glioblastoma in the Elderly, New England Journal of Medicine, vol.356, issue.15, pp.1527-1535, 2007. ,
DOI : 10.1056/NEJMoa065901
A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma, International Journal of Radiation Oncology*Biology*Physics, vol.92, issue.5, pp.986-992, 2015. ,
DOI : 10.1016/j.ijrobp.2015.04.038
Multidrug resistance: Physiological principles and nanomedical solutions, Advanced Drug Delivery Reviews, vol.65, issue.13-14, pp.13-14, 2013. ,
DOI : 10.1016/j.addr.2013.09.018
URL : http://europepmc.org/articles/pmc3939439?pdf=render
Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles, International Journal of Pharmaceutics, vol.479, issue.1, pp.138-149, 2015. ,
DOI : 10.1016/j.ijpharm.2014.12.070
IDH1 Gene Mutations: A New Paradigm in Glioma Prognosis and Therapy?, The Oncologist, vol.15, issue.2, pp.196-199, 2010. ,
DOI : 10.1634/theoncologist.2009-0218
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice, Nature, vol.367, issue.6464, pp.645-648, 1994. ,
DOI : 10.1038/367645a0
[14th scientific meeting of the Growth Factors Club Stem cells and cancer], Bull Cancer, vol.94, issue.3, pp.307-312, 2007. ,
[Genetic and molecular abnormalities of glioblastomas (GBM)], Bull Cancer, vol.97, issue.11, pp.1389-1407, 2010. ,
Phase II study of bevacizumab and temsirolimus combination therapy for recurrent glioblastoma multiforme, Anticancer Res, vol.33, issue.4, pp.1657-1660, 2013. ,
Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma, Neuro-Oncology, vol.15, issue.3, 2015. ,
DOI : 10.1016/S1470-2045(14)70314-6
Identification of Pancreatic Cancer Stem Cells, Cancer Research, vol.67, issue.3, pp.1030-1037, 2007. ,
DOI : 10.1158/0008-5472.CAN-06-2030
Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma, Oncogene, vol.67, issue.13, pp.1619-1628, 2015. ,
DOI : 10.1158/0008-5472.CAN-07-5019
cellules souches cancéreuses: les racines du mal ?, 2015. ,
The 2007 WHO Classification of Tumours of the Central Nervous System, Acta Neuropathologica, vol.64, issue.2, pp.97-109, 2007. ,
DOI : 10.1093/jnen/60.9.863
A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K, Neuro-Oncology, vol.14, issue.(12), pp.1261-1269, 2015. ,
DOI : 10.1200/jco.2013.31.18_suppl.lba509
The WNKs: Atypical Protein Kinases With Pleiotropic Actions, Physiological Reviews, vol.15, issue.1, pp.177-219, 2011. ,
DOI : 10.1042/BST0320817
Emerging roles for WNK kinases in cancer, Cellular and Molecular Life Sciences, vol.102, issue.8, pp.1265-1276, 2010. ,
DOI : 10.1152/physiol.00015.2006
Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma, Annals of Oncology, vol.117, issue.1, pp.1596-1603, 2009. ,
DOI : 10.1002/ijc.21121
A brain for all seasons: cyclical anatomical changes in song control nuclei of the canary brain, Science, vol.214, issue.4527, pp.1368-1370, 1981. ,
DOI : 10.1126/science.7313697
Neuro-oncologie de l'adulte : Glioblastome de l'adulte Retrieved 28, 2011. ,
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011, Neuro-Oncology, vol.94, issue.20, pp.1-63, 2014. ,
DOI : 10.1093/jnci/94.20.1537
CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumors, BMC Cancer, vol.4, issue.5, p.66, 2010. ,
DOI : 10.1016/j.stem.2009.03.003
URL : https://hal.archives-ouvertes.fr/inserm-00663773
[Histone deacetylase inhibitors: highlight on epigenetic regulation], Bull Cancer, vol.97, issue.8, pp.917-935, 2010. ,
Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells, Nature, vol.156, issue.7120, pp.761-765, 2006. ,
DOI : 10.1006/exnr.1998.6998
[General overview on DNA repair], Bull Cancer, vol.98, issue.3, pp.229-237, 2011. ,
A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy, Neuro-Oncology, vol.318, issue.5848, pp.95-103, 2010. ,
DOI : 10.1126/science.1142946
The Embryonic Rest Hypothesis of Cancer Development: 150 Years Later, Trends in Stem Cell Proliferation and Cancer Research. H. U. E. Rodrigo R. Resende, pp.51-64, 2013. ,
DOI : 10.1007/978-94-007-6211-4_3
Phase II Study of Neoadjuvant Imatinib in Glioblastoma: Evaluation of Clinical and Molecular Effects of the Treatment, Clinical Cancer Research, vol.15, issue.19, pp.6258-6266, 2009. ,
DOI : 10.1158/1078-0432.CCR-08-1867
Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma, Journal of Neuro-Oncology, vol.65, issue.2, pp.219-230, 2010. ,
DOI : 10.1016/j.ijrobp.2006.01.018
Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma, Cancer, vol.97, issue.19, pp.4759-4767, 2012. ,
DOI : 10.1007/s11060-009-0008-0
Immunotherapy advances for glioblastoma, Neuro-Oncology, vol.20, issue.18, pp.1441-1458, 2014. ,
DOI : 10.1097/WNR.0b013e32833188f7
URL : https://academic.oup.com/neuro-oncology/article-pdf/16/11/1441/7639930/nou212.pdf
Recherches sur le traitement du cancer, par la compression méthodique simple ou combinée, et sur l'histoire général de la même maladie, 1829. ,
Ein Beitrag zur Entwicklungsgeschichte der Krebshaften geschwülste, D. Klinik, vol.6, pp.170-175, 1854. ,
Stem cells, cancer, and cancer stem cells, Nature, vol.414, issue.6859, pp.105-111, 2001. ,
DOI : 10.1038/35102167
Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system, Science, vol.255, issue.5052, pp.1707-1710, 1992. ,
DOI : 10.1126/science.1553558
Identification and expansion of human colon-cancer-initiating cells, Nature, vol.37, issue.7123, pp.111-115, 2007. ,
DOI : 10.1038/ng1005-1027
Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells, Nature, vol.200, issue.7325, pp.824-828, 2010. ,
DOI : 10.4161/cc.8.1.7533
Phase II Trial of Gefitinib in Recurrent Glioblastoma, Journal of Clinical Oncology, vol.22, issue.1, pp.133-142, 2004. ,
DOI : 10.1200/JCO.2004.08.110
The regulation of salt transport and blood pressure by the WNK-SPAK/OSR1 signalling pathway, Journal of Cell Science, vol.121, issue.20, pp.3293-3304, 2008. ,
DOI : 10.1242/jcs.029223
Abbreviated Course of Radiation Therapy in Older Patients With Glioblastoma Multiforme: A Prospective Randomized Clinical Trial, Journal of Clinical Oncology, vol.22, issue.9, pp.1583-1588, 2004. ,
DOI : 10.1200/JCO.2004.06.082
CIC and FUBP1 mutations in oligodendrogliomas, oligoastrocytomas and astrocytomas, Acta Neuropathologica, vol.226, issue.6, pp.853-860, 2012. ,
DOI : 10.1002/path.2995
Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma, Journal of Clinical Oncology, vol.28, issue.31, pp.4722-4729, 2010. ,
DOI : 10.1200/JCO.2010.28.6963
Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex, Science, vol.307, issue.5712, pp.1098-1101, 2005. ,
DOI : 10.1126/science.1106148
Regression of metastatic melanoma in a patient by antibody targeting of cancer stem cells, Oncotarget, vol.3, issue.1, pp.22-30, 2012. ,
DOI : 10.18632/oncotarget.437
A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study, Neuro-Oncology, vol.352, issue.10, pp.854-861, 2015. ,
DOI : 10.1056/NEJMoa043330
Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution, Cell, vol.138, issue.5, pp.822-829, 2009. ,
DOI : 10.1016/j.cell.2009.08.017
Identification of human brain tumour initiating cells, Nature, vol.64, issue.suppl. 1, pp.396-401, 2004. ,
DOI : 10.1158/0008-5472.CAN-04-1364
Dynamics of Hippocampal Neurogenesis in Adult Humans, Cell, vol.153, issue.6, pp.1219-1227, 2013. ,
DOI : 10.1016/j.cell.2013.05.002
URL : https://hal.archives-ouvertes.fr/hal-00839513
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial, The Lancet Oncology, vol.7, issue.5, pp.392-401, 2006. ,
DOI : 10.1016/S1470-2045(06)70665-9
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial, The Lancet Oncology, vol.10, issue.5, pp.459-466, 2009. ,
DOI : 10.1016/S1470-2045(09)70025-7
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma, New England Journal of Medicine, vol.352, issue.10, pp.987-996, 2005. ,
DOI : 10.1056/NEJMoa043330
Sexually dimorphic RB inactivation underlies mesenchymal glioblastoma prevalence in males, Journal of Clinical Investigation, vol.124, issue.9, pp.4123-4133, 2014. ,
DOI : 10.1172/JCI71048DS1
URL : http://www.jci.org/articles/view/71048/files/pdf
Neural stem cells, tumour stem cells and brain tumours: Dangerous relationships?, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1776, issue.2, pp.125-137, 2007. ,
DOI : 10.1016/j.bbcan.2007.07.006
Functional Roles of Electrogenic Sodium Bicarbonate Cotransporter NBCe1 in Ocular Tissues, The Open Ophthalmology Journal, vol.6, issue.1, pp.36-41, 2012. ,
DOI : 10.2174/1874364101206010036
Defective membrane expression of the Na+-HCO3- cotransporter NBCe1 is associated with familial migraine, Proceedings of the National Academy of Sciences, vol.103, issue.25, pp.15963-15968, 2010. ,
DOI : 10.1073/pnas.0602250103
Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors, Cell, vol.126, issue.4, pp.663-676, 2006. ,
DOI : 10.1016/j.cell.2006.07.024
Acute promyelocytic leukemia: evolving therapeutic strategies, Blood, vol.99, issue.3, pp.759-767, 2002. ,
DOI : 10.1182/blood.V99.3.759
URL : http://www.bloodjournal.org/content/bloodjournal/99/3/759.full.pdf
PTEN Gene and Integrin Signaling in Cancer, JNCI Journal of the National Cancer Institute, vol.96, issue.11, pp.1820-1828, 1999. ,
DOI : 10.1073/pnas.96.11.6199
The Electrogenic Sodium Bicarbonate Cotransporter NBCe1 Is a High-Affinity Bicarbonate Carrier in Cortical Astrocytes, Journal of Neuroscience, vol.34, issue.4, pp.1148-1157, 2014. ,
DOI : 10.1523/JNEUROSCI.2377-13.2014
Colon Cancer Stem Cells Dictate Tumor Growth and Resist Cell Death by Production of Interleukin-4, Cell Stem Cell, vol.1, issue.4, pp.389-402, 2007. ,
DOI : 10.1016/j.stem.2007.08.001
Potential Use of Polymeric Nanoparticles for Drug Delivery Across the Blood-Brain Barrier, Current Medicinal Chemistry, vol.20, issue.17, pp.2212-2225, 2013. ,
DOI : 10.2174/0929867311320170006
Effect of valproic acid on the outcome of glioblastoma multiforme, British Journal of Neurosurgery, vol.16, issue.3, pp.347-354, 2012. ,
DOI : 10.3727/096504007783338340
Recent developments in the use of chemotherapy in brain tumours, European Journal of Cancer, vol.42, issue.5, pp.582-588, 2006. ,
DOI : 10.1016/j.ejca.2005.06.031
Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma, CA: A Cancer Journal for Clinicians, vol.60, issue.3, pp.166-193, 2010. ,
DOI : 10.3322/caac.20069
Brain tumour stem cells, Nature Reviews Cancer, vol.6, issue.6, pp.425-436, 2006. ,
DOI : 10.1593/neo.03427
Phase II trial of bevacizumab and irinotecan in recurrent malignant gliomaBevacizumab plus irinotecan in recurrent glioblastoma multiformeNotch promotes radioresistance of glioma stem cells, Clin Cancer Res J Clin Oncol Stem Cells, vol.13, issue.281, pp.1253-1259, 2007. ,
Overexpression of the EGF Receptor and p53 Mutations are Mutually Exclusive in the Evolution of Primary and Secondary Glioblastomas, Brain Pathology, vol.3, issue.3, pp.217-223, 1996. ,
DOI : 10.1002/ijc.2910560608
IDH1 Mutations Are Early Events in the Development of Astrocytomas and Oligodendrogliomas, The American Journal of Pathology, vol.174, issue.4, pp.1149-1153, 2009. ,
DOI : 10.2353/ajpath.2009.080958
Out of Eden: Stem Cells and Their Niches, Science, vol.287, issue.5457, pp.1427-1430, 2000. ,
DOI : 10.1126/science.287.5457.1427
Phase I/II Study of Imatinib Mesylate for Recurrent Malignant Gliomas: North American Brain Tumor Consortium Study 99-08, Clinical Cancer Research, vol.12, issue.16, pp.4899-4907, 2006. ,
DOI : 10.1158/1078-0432.CCR-06-0773
Glioblastoma specific antigens, GD2 and CD90, are not involved in cancer stemness, Anatomy & Cell Biology, vol.48, issue.1, pp.44-53, 2015. ,
DOI : 10.5115/acb.2015.48.1.44
URL : http://europepmc.org/articles/pmc4371180?pdf=render
IRBIT governs epithelial secretion in mice by antagonizing the WNK/SPAK kinase pathway, Journal of Clinical Investigation, vol.121, issue.3, pp.956-965, 2011. ,
DOI : 10.1172/JCI43475DS1
Survival analysis for valproic acid use in adult glioblastoma multiforme: A meta-analysis of individual patient data and a systematic review, Seizure, vol.23, issue.10, pp.830-835, 2014. ,
DOI : 10.1016/j.seizure.2014.06.015
Chemical Library Screening and Structure-Function Relationship Studies Identify Bisacodyl as a Potent and Selective Cytotoxic Agent Towards Quiescent Human Glioblastoma Tumor Stem-Like Cells, PLOS ONE, vol.138, issue.4, p.134793, 2015. ,
DOI : 10.1371/journal.pone.0134793.s015
URL : https://hal.archives-ouvertes.fr/hal-01223842
Isocitrate dehydrogenase mutations may be a protective mechanism in glioma patients, Medical Hypotheses, vol.76, issue.4, pp.602-603, 2011. ,
DOI : 10.1016/j.mehy.2011.01.011
Topological Location and Structural Importance of the NBCe1-A Residues Mutated in Proximal Renal Tubular Acidosis, Journal of Biological Chemistry, vol.281, issue.18, pp.13416-13426, 2010. ,
DOI : 10.1006/meth.1998.0615